Urology
Volume 61, Issue 1 , Pages 13-14 , January 2003

Informed consent for prostate-specific antigen screening

  • H.Ballentine Carter

      Affiliations

    • Department of Urology, Johns Hopkins University School of Medicine, James Buchanan Brady Urological Institute, Johns Hopkins Hospital, Baltimore, Maryland, USA
    • Corresponding Author InformationReprint requests: H. Ballentine Carter, M.D., Department of Urology, 403 Marburg, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, MD 21287-2101, USA

Received 24 June 2002 ,Accepted 14 August 2002.

References 

  1. Gann PH. Interpreting trends in prostate cancer incidence and mortality. Epidemiology. 1997;8:117–120
  2. Etzioni R, Berry KM, Legler JM, et al.  Prostate-specific antigen testing in black and white men (an analysis of medicare claims from 1991–1998). Urology. 2002;59:251–255
  3. Dunn AS, Shridharani KV, Lou W, et al.  Physician-patient discussions of controversial cancer screening tests. Am J Prev Med. 2001;20:130–134
  4. Giesen D. The patient’s right to know—a comparative law perspective. Med Law. 1993;12:553–565
  5. Chan EC, Sulmasy DP. What should men know about prostate-specific antigen screening before giving informed consent?. Am J Med. 1998;105:266–274
  6. Thompson I, Carroll P, Coley C, et al.  American Urological Association   Prostate-specific antigen (PSA) best practice policy. Oncology. 2000;14:267–286
  7. Smith RA, Mettlin CJ, Davis KJ, et al.  American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin. 2000;50:34–49
  8. Coley CM, Barry MJ, Mulley AG. Clinical guideline (Part III. Screening for prostate cancer). Ann Intern Med. 1997;126:480–484
  9. Newschaffer CJ, Otani K, McDonald MK, et al.  Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 2000;92:613–621
  10. Ries LAG, Eisner MP, Kosary CL, et al: (Eds): SEER Cancer Statistics Review, 1973–1999. Bethesda, National Cancer Institute, 2002
  11. Gronberg H, Damber L, Jonson H, et al.  Prostate cancer mortality in northern Sweden, with special reference to tumor grade and patient age. Urology. 1997;49:374–378

PII: S0090-4295(02)02009-5

Urology
Volume 61, Issue 1 , Pages 13-14 , January 2003

Article Tools